FRISIUM

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Osta se nyt

Lataa Pakkausseloste (PIL)
25-07-2022
Lataa Valmisteyhteenveto (SPC)
29-09-2021

Aktiivinen ainesosa:

CLOBAZAM

Saatavilla:

SANOFI ISRAEL LTD

ATC-koodi:

N05BA09

Lääkemuoto:

TABLETS

Koostumus:

CLOBAZAM 10 MG

Antoreitti:

PER OS

Prescription tyyppi:

Required

Valmistaja:

SANOFI WINTHROP INDUSTRIE, FRANCE

Terapeuttinen ryhmä:

CLOBAZAM

Terapeuttinen alue:

CLOBAZAM

Käyttöaiheet:

Frisium is a 1,5-benzodiazepine indicated for the short-term relief (2 – 4 weeks) only of anxiety in adult patients that is severe, disabling or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short term psychosomatic, organic or psychotic illness.The use of Frisium to treat short-term “mild” anxiety is inappropriate and unsuitable.

Valtuutus päivämäärä:

2022-06-30

Pakkausseloste

                                PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986
This medicine is dispensed with a doctor’s prescription only
FRISIUM
Tablets, 10 mg
ACTIVE INGREDIENT:
Each tablet contains:
Clobazam 10 mg
Inactive ingredients: See section 2 – ‘Important information about
some
of the ingredients of the medicine’ and section 6 – ‘Further
Information’.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THIS
MEDICINE.
This leaflet contains concise information about the medicine. If you
have
further questions, refer to the doctor or pharmacist.
This medicine has been prescribed to treat you. Do not pass it on to
others. It may harm them even if it seems to you that their medical
condition is similar.
INTRODUCTION TO THE PATIENT LEAFLET FOR BENZODIAZEPINES
-
This medicine belongs to the benzodiazepine group, which has special
characteristics which require a lot of caution during use.
-
It is very important to be under close medical supervision when taking
this medicine.
-
When you are taking this medicine, be sure to refer to a doctor after
2-4
weeks, as the treatment is meant for short periods only.
-
Prolonged use of the medicine may reduce the effect of the medicine.
-
Such use may cause a severe dependence effect, which will make it hard
for the patient to stop taking the medicine.
- Unregulated discontinuation of treatment is accompanied with
withdrawal effects, such as: tension, irritability, confusion, tremor,
insomnia, abdominal pains, vomiting, nausea, sweating, spasms.
- Sometimes, prolonged use of the medicine may cause behavioral
changes and bothersome thoughts.
-
It is recommended, especially for the elderly, to be careful when
walking,
as the medicine impairs alertness and sometimes body movement
coordination, and there is therefore danger of tripping or falling.
Taking this medicine with opioids, other medicines that suppress the
central nervous system (including drugs) or alcohol, may cause deep
sleepiness, breathing difficulties (respiratory depressio
                                
                                Lue koko asiakirja
                                
                            

Valmisteyhteenveto

                                [לוגו מדינת ישראל] [http://www.gov.il/]
[http://www.gov.il/] [לוגו משרד הבריאות] [לוגו משרד
הבריאות] [*5400]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
הציבור הרחב עסקים ומוסדות עובדים
בבריאות חפש מידע
תפריט	*
[סגירה]
סגור	*
דף הבית [http://www.health.gov.il/]	*
אודות	*
אודות המשרד
[http://www.health.gov.il/About/Pages/about_us.aspx]	*
תוכנית עבודה
[http://www.health.gov.il/About/Pages/Agenda.aspx]	*
תקציב המשרד
[http://www.health.gov.il/About/Pages/budget.aspx]	*
תרשים מבנה ארגוני
[http://www.health.gov.il/About/Pages/OrganizationalStructureDiagram.aspx]	*
בעלי תפקידים
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx]	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx?tab=3]	*
אמנת שירות
[http://www.health.gov.il/About/sla/Pages/default.aspx]	*
אותות ופרסים
[http://www.health.gov.il/About/Awards/Pages/mifal.aspx]	*
פרוייקטים תשתיתיים
[http://www.health.gov.il/About/projects/shared_medical_info/Pages/default.aspx]	*
דרושים
[http://www.health.gov.il/About/Careers/Pages/default.aspx]	*
מנכ"לי משרד הבריאות לדורותיהם
[http://www.health.gov.il/About/Pages/GeneralManegerHistory.aspx]	*
יחידות המשרד	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/UnitsOffice/LB/Pages/default.aspx]	*
וועדות ומועצות
[http://www.health.gov.il/Services/Committee/Pages/CommitteeList.aspx]	*
נושאים	*
בריאות הנפש
[http://www.health.gov.il/Subjects/mental_health/Pages/default.aspx]	*
בריאות הסביבה
[http://www.health.gov.il/Subjects/Environmental_Health/
                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Pakkausseloste Pakkausseloste arabia 25-07-2022
Pakkausseloste Pakkausseloste heprea 12-10-2022

Etsi tähän tuotteeseen liittyviä ilmoituksia

Näytä asiakirjojen historia